期刊文献+

罗哌卡因复合舒芬太尼硬膜外分娩镇痛用于瘢痕子宫产妇阴道分娩的镇痛效果 被引量:18

Analgesic efficacy of epidural labor analgesia with ropivacaine combined with sulfentanil in the full term pregnant puerperants with scar uterus undergoing vaginal delivery
原文传递
导出
摘要 目的观察不同浓度罗哌卡因复合舒芬太尼硬膜外分娩镇痛用于瘢痕子宫产妇再次足月妊娠阴道分娩的镇痛效果。方法接受分娩镇痛的瘢痕子宫再次妊娠产妇120例随机分为四组,每组30例。A、B和C组分别采用0.1%罗哌卡因、0.15%罗哌卡因和0.2%罗哌卡因复合舒芬太尼0.5μg/ml行硬膜外分娩镇痛,D组未接受镇痛分娩作为对照。比较分娩期VAS疼痛评分、产程时间、产后出血量、新生儿Apgar评分和催产素使用情况。结果 A、B和C组分娩镇痛效果均较满意,VAS疼痛评分依次为C组<B组<A组(P<0.05)。B组第一产程时间短于D组(P<0.05);C组第二产程时间较其他组延长(P<0.05),且产后出血量也多于其他组(P<0.05)。B组和C组催产素使用率高于D组(P<0.05),但无一例发生子宫破裂。四组顺产率、新生儿1-min和5-min Apgar评分相仿(P>0.05)。结论罗哌卡因复合舒芬太尼用于瘢痕子宫产妇再次妊娠分娩镇痛效果满意,推荐镇痛药物为0.15%罗哌卡因+舒芬太尼0.5μg/ml。 Objective To observe the analgesic efficacy of epidural labor analgesia with sulfentanil combined with different concentrations of ropivacaine in the full term pregnant puerperants with scar uterus undergoing vaginal delivery.Methods A total of 120 full term pregnant puerperants with scar uterus undergoing vaginal delivery was assigned into four groups with 30 cases each.The epidural labor analgesia with sulfentanil 0.5μg/ml combined with 0.1%(group A),0.15%(group B)or 0.2%ropivacaine(group C)was performed,which was not used in group D as the control.The VAS pain score during vaginal delivery,the times of birth process,postpartum blood loss,neonatal Apgar score and the use of oxytocin were compared among four groups.Results The analgesic efficacy of epidural labor analgesia was all satisfied in groups of A,B and C with an order of C〈B〈A in pain score(P〈0.05).The first birth process was shorter in group B than that in group D(P〈0.05).The second birth process was longer in group C than that in groups of D,A and B with more blood loss(P〈0.05).The propotion of puerperants with the use of oxytocin was more in groups of C and B than that in group D(P〈0.05),but there was no case with hysterorrhexis.The rate of natural delivery and neonatal one-minute and five-minute Apgar score were not significantly different among four groups(P〉0.05).Conclusion Analgesic efficacy of epidural labor analgesia with sulfentanil combined with ropivacaine is satisfactory in the full term pregnant puerperants with scar uterus undergoing vaginal delivery,for which 0.15% ropivacaine combined with sulfentanil0.5μg/ml is recommended.
作者 聂鑫 孙彩凤 王慧艳 褚国强 居慧慧 NIE Xin;SUN Caifeng;WANG Huiyan(Department of Anesthesiology,Affiliated Changzhou Maternal and Child Health Hospital,Nanjing Medical University,Changzhou 213000,CHINA)
出处 《江苏医药》 CAS 2018年第9期1008-1010,共3页 Jiangsu Medical Journal
基金 江苏省妇幼健康资助项目(F201545)
关键词 硬膜外分娩镇痛 罗哌卡因 舒芬太尼 瘢痕子宫 阴道分娩 Epidural labor analgesia Ropivacaine Sulfentanil Scar uterus Vaginal delivery
  • 相关文献

参考文献6

二级参考文献53

  • 1陈敬峰,彭家英,章艳,刘峰,传翔,罗莹玉.舒芬太尼与芬太尼硬膜外自控镇痛用于分娩镇痛的比较[J].医学信息(医学与计算机应用),2014,0(25):63-64. 被引量:1
  • 2黄瑾.瘢痕子宫再次分娩方式对产妇影响分折[J].中国社区医师(医学专业),2010,12(23):133-134. 被引量:7
  • 3万震威,杨光辉,黄燕虹.左旋布比卡因、布比卡因和罗哌卡因腰麻用于妇科手术的比较[J].实用诊断与治疗杂志,2005,19(8):558-559. 被引量:6
  • 4马爱兵,曹敏,郑振荣.腰麻—硬膜外阻滞联合PCEA用于分娩镇痛50例效果观察[J].山东医药,2007,47(23):90-91. 被引量:4
  • 5Bremerich DH, Waibel HI, Mierdl S, et al. Comparison of continuous background infusion plus demand dose and demand-only parturient-controlled epidural analgesia (PCEA) using ropivacaine combined with sufentanil for labor and delivery [ J ]. Int J Obstet Anesth,2005,14 ( 2 ) : 114-120.
  • 6Van de M, Dreelinck R, Dubois J, et al. Determination of the full dose-response relation of intrathecal bupivacaine, levobupivacaine, and ropivaeaine, combined with sufentanil, for labor analgesia[J].Anesthesiology,2007,106( 1 ) :149-516.
  • 7Boselli E, Debon R, Duflo F, et al. Ropivacaine 0.15% plus sufentanil 0.5 microg/ml and ropivacaine 0. 10% plus sufentanil 0. 5 nilcrog/ml are equivalent for patient-controlled epidund analgesia during labor[J]. Anesth Analg,2003,96(4) :1173-1177.
  • 8Bonilla Y.The past is made by walking:labor activism and historical production in postcolonial guadeloupe [J].Cult Anthropol,2011,26(3):313-339.
  • 9Hollins Martin C J,Martin CR.A narrative review of maternal physical activity during labour and its effects upon length of first stage [J].Complement Ther Clin Pract,2013,19(1):44-49.
  • 10Morita M,Le Marchand L,Kono S,et al.Genetic polymorphisms of CYP2E1 and risk of colorectal cancer:the Fukuoka Colorectal Cancer Study[J].Cancer Epidemiol Biomarkers Prey,2009,18(1):235-241.

共引文献204

同被引文献129

引证文献18

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部